You are here

Clinical Trials for Head and Neck/Otolaryngological Cancers-Under construction

Head and Neck Oncology is the study and treatment of cancers of the mouth, throat, larynx, nose and sinuses, thyroid, salivary glands and skin from the shoulders and up.  It is managed through the UI Health Department of Otolaryngology, commonly known as ENT or ear, nose and throat.  Though these cancers are most commonly found as a result of alcohol and tobacco abuse, their incidence is increasing as a result of the Human Papilloma Virus, also known as HPV. A vaccine for HPV has been FDA approved and actively in use for the past 9 years, and new variations of the vaccine are currently in development to make it more accessible.  

The HPV vaccine is one example of the critical job that Clinical Trials plays in the fight against cancer.  A vaccine, as with any pharmaceutical, must go through the Clinical Trials process to rise from a compound to a translatable product that is safe for human consumption.  It is important to note that Clinical Trials have specific eligibility requirements, often pertinent to age, gender, diagnosis, staging and area of metastasis.  This is to help determine the efficacy of a drug and any potential adverse reactions or toxicities.  If you are interested in participating in a Clinical Trial, please contact your oncologist or the Clinical Trials Office at 312-996-9272.

Please see below or click the following link for information about Head and Neck Cancer Trials Open to Accrual.

Please click here for information about the UI Health Head and Neck Cancer Surgery Program